Mantle Cell Lymphoma – What Treatment Should I Choose for A Newly Diagnosed Patient?


Upon viewing this session, you will be able to:
• Identify clinical and biologic risk factors in MCL
• Discuss optimal initial therapy options in young/fit and older or unfit patients
• Explain efficacy and limitations of maintenance rituximab
• Summarize data supporting new agents and novel strategies


  • Brad Kahl, MD, Washington University School of Medicine in St. Louis


Member Type Price
List Price $30.00
Active, International, Emeritus, and Honorary Members $20.00
Associate, International Associate, Student, and Resident Members $20.00
back to top